A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells.

Pluripotent mesenchymal stem cells (MSCs) are bone marrow stromal progenitor cells that can differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages. Several signaling pathways have been shown to regulate the lineage commitment and terminal differentiation of MSCs. Here, we conducted a comprehensive analysis of the 14 types of bone morphogenetic protein (BMPs) for their abilities to regulate multilineage specific differentiation of MSCs. We found that most BMPs exhibited distinct abilities to regulate the expression of Runx2, Sox9, MyoD, and PPARgamma2. Further analysis indicated that BMP-2, BMP-4, BMP-6, BMP-7, and BMP-9 effectively induced both adipogenic and osteogenic differentiation in vitro and in vivo. BMP-induced commitment to osteogenic or adipogenic lineage was shown to be mutually exclusive. Overexpression of Runx2 enhanced BMP-induced osteogenic differentiation, whereas knockdown of Runx2 expression diminished BMP-induced bone formation with a decrease in adipocyte accumulation in vivo. Interestingly, overexpression of PPARgamma2 not only promoted adipogenic differentiation, but also enhanced osteogenic differentiation upon BMP-2, BMP-6, and BMP-9 stimulation. Conversely, MSCs with PPARgamma2 knockdown or mouse embryonic fibroblasts derived from PPARgamma2(-/-) mice exhibited a marked decrease in adipogenic differentiation, coupled with reduced osteogenic differentiation and diminished mineralization upon BMP-9 stimulation, suggesting that PPARgamma2 may play a role in BMP-induced osteogenic and adipogenic differentiation. Thus, it is important to understand the molecular mechanism behind BMP-regulated lineage divergence during MSC differentiation, as this knowledge could help us to understand the pathogenesis of skeletal diseases and may lead to the development of strategies for regenerative medicine.

[1]  A. Zapata,et al.  Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency. , 2011, Stem cells and development.

[2]  I. Jung,et al.  Enhanced adipogenic differentiation and reduced collagen synthesis induced by human periodontal ligament stem cells might underlie the negative effect of recombinant human bone morphogenetic protein-2 on periodontal regeneration. , 2011, Journal of periodontal research.

[3]  T. He,et al.  Role of RANK-RANKL-OPG Axis in Cranial Suture Homeostasis , 2011, The Journal of craniofacial surgery.

[4]  F. Syed,et al.  Integrative physiology of the aging bone: insights from animal and cellular models , 2010, Annals of the New York Academy of Sciences.

[5]  Anxun Wang,et al.  Bone Morphogenetic Protein Receptor in the Osteogenic Differentiation of Rat Bone Marrow Stromal Cells , 2010, Yonsei medical journal.

[6]  P. Thomsen,et al.  Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. , 2010, Tissue engineering. Part A.

[7]  Sun-Woong Kang,et al.  Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells. , 2010, Biomaterials.

[8]  T. He,et al.  Insulin-like Growth Factor 2 (IGF-2) Potentiates BMP-9-Induced Osteogenic Differentiation and Bone Formation , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  B. Boyan,et al.  Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. , 2010, Biomaterials.

[10]  T. He,et al.  Therapeutic Implications of PPARγ in Human Osteosarcoma , 2010, PPAR research.

[11]  T. He,et al.  Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. , 2009, Differentiation; research in biological diversity.

[12]  S. B. Peres,et al.  Mechanisms of obesity and related pathologies: Transcriptional control of adipose tissue development , 2009, The FEBS journal.

[13]  E. Hoffman,et al.  Differences in fat and muscle mass associated with a functional human polymorphism in a post‐transcriptional BMP2 gene regulatory element , 2009, Journal of cellular biochemistry.

[14]  D. Ornitz,et al.  Fibroblast growth factor expression during skeletal fracture healing in mice , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[15]  Wei Jiang,et al.  Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. , 2007, Gene.

[16]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  K. Kinzler,et al.  A protocol for rapid generation of recombinant adenoviruses using the AdEasy system , 2007, Nature Protocols.

[18]  T. He,et al.  Wnt signaling and human diseases: what are the therapeutic implications? , 2007, Laboratory Investigation.

[19]  M. Lane,et al.  Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: Role of the BMP-4 gene , 2006, Proceedings of the National Academy of Sciences.

[20]  S. Mowla,et al.  Effect of Bone Morphogenetic Protein‐4 (BMP‐4) on Adipocyte Differentiation from Mouse Embryonic Stem Cells , 2006, Anatomia, histologia, embryologia.

[21]  A. Montag,et al.  CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells , 2006, Molecular and Cellular Biology.

[22]  S. Ishii,et al.  Schnurri-2 controls BMP-dependent adipogenesis via interaction with Smad proteins. , 2006, Developmental cell.

[23]  J. Wrana,et al.  The disparate role of BMP in stem cell biology , 2005, Oncogene.

[24]  Thomas Benjamin,et al.  TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.

[25]  Jiwang Zhang,et al.  BMP signaling and stem cell regulation. , 2005, Developmental biology.

[26]  M. Riminucci.  [Bone stem cells]. , 2005, Pathologica.

[27]  J. Cigudosa,et al.  Spontaneous human adult stem cell transformation. , 2005, Cancer research.

[28]  P. Guldberg,et al.  Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. , 2005, Cancer research.

[29]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[30]  A. Parfitt,et al.  Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. , 2005, Endocrinology.

[31]  Derrick E Rancourt,et al.  Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: Effect of cofactors on differentiating lineages , 2005, BMC Developmental Biology.

[32]  A. Montag,et al.  Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[33]  L. Sommer,et al.  Wnt signaling and the regulation of stem cell function. , 2004, Current opinion in cell biology.

[34]  B. Lecka-Czernik,et al.  Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR‐γ2 transcription factor and TGF‐β/BMP signaling pathways , 2004, Aging cell.

[35]  S. Morrison,et al.  Diverse mechanisms regulate stem cell self-renewal. , 2004, Current opinion in cell biology.

[36]  A. Wynshaw-Boris,et al.  The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation. , 2004, Current opinion in genetics & development.

[37]  D. Miao,et al.  Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. , 2004, The Journal of endocrinology.

[38]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[39]  Wei Jiang,et al.  Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells* , 2004, Journal of Biological Chemistry.

[40]  R. Tuan,et al.  Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy , 2004, Journal of cellular and molecular medicine.

[41]  J. Gimble,et al.  Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. , 2004, Current opinion in pharmacology.

[42]  F. Barry,et al.  Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.

[43]  Kozo Nakamura,et al.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.

[44]  M. Fussenegger,et al.  Dual-regulated expression of C/EBP-alpha and BMP-2 enables differential differentiation of C2C12 cells into adipocytes and osteoblasts. , 2004, Nucleic acids research.

[45]  Hongwei Cheng,et al.  Transcriptional characterization of bone morphogenetic proteins (BMPs)‐mediated osteogenic signaling , 2003, Journal of cellular biochemistry.

[46]  R. J. Dumont,et al.  Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat , 2003, Gene Therapy.

[47]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[48]  Guang-Quan Zhao,et al.  Consequences of knocking out BMP signaling in the mouse , 2003, Genesis.

[49]  E. Caterson,et al.  Multilineage Differentiation of Adult Human Bone Marrow Progenitor Cells Transduced with Human Papilloma Virus Type 16 E6/E7 Genes , 2002, Calcified Tissue International.

[50]  J Denton,et al.  Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis , 2002, Journal of clinical pathology.

[51]  Jeffrey L. Wrana,et al.  Signal Transduction by the TGF-β Superfamily , 2002, Science.

[52]  F. Kraemer,et al.  Human BMP‐7/OP‐1 induces the growth and differentiation of adipocytes and osteoblasts in bone marrow stromal cell cultures * , 2001, Journal of cellular biochemistry.

[53]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[54]  G. Karsenty,et al.  The osteoblast: a sophisticated fibroblast under central surveillance. , 2000, Science.

[55]  T. Komori,et al.  Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. , 2000, Biochemical and biophysical research communications.

[56]  K. Seuwen,et al.  Bone morphogenetic protein‐2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone) , 2000, FEBS letters.

[57]  G. Karsenty,et al.  The family of bone morphogenetic proteins. , 2000, Kidney international.

[58]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[59]  M. Aizawa,et al.  Osteogenesis coordinated in C3H10T1/2 cells by adipogenesis-dependent BMP-2 expression system. , 2000, Tissue engineering.

[60]  W. Kwong,et al.  Bmp-4 requires the presence of the digits to initiate programmed cell death in limb interdigital tissues. , 2000, Developmental biology.

[61]  K. Kinzler,et al.  PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs , 1999, Cell.

[62]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[63]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[64]  F. Kaplan,et al.  Progressive Osseous Heteroplasia , 2000 .

[65]  A. Reddi,et al.  Role of morphogenetic proteins in skeletal tissue engineering and regeneration , 1998, Nature Biotechnology.

[66]  A. Parfitt,et al.  Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[67]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[68]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[69]  I. Asahina,et al.  Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. , 1996, Experimental cell research.

[70]  J. Gimble,et al.  Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells , 1995, Journal of cellular biochemistry.

[71]  G. Gross,et al.  Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. , 1993, DNA and cell biology.

[72]  M. Rozman,et al.  Variations of fat tissue fraction in abnormal human bone marrow depend both on size and number of adipocytes: a stereologic study. , 1990, Blood.

[73]  C. Heidelberger,et al.  Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. , 1973, Cancer research.

[74]  P Meunier,et al.  Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. , 1971, Clinical orthopaedics and related research.

[75]  A. Friedenstein,et al.  Osteogenesis in transplants of bone marrow cells. , 1966, Journal of embryology and experimental morphology.

[76]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[77]  A. Montag,et al.  Regulation of osteogenic differentiation during skeletal development. , 2008, Frontiers in bioscience : a journal and virtual library.

[78]  L. Mosekilde,et al.  Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis , 2004, Biogerontology.

[79]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[80]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[81]  J. Wrana,et al.  Signal transduction by the TGF-beta superfamily. , 2002, Science.

[82]  K. Lyons,et al.  Bone morphogenetic protein-3 is a negative regulator of bone density , 2001, Nature Genetics.

[83]  T. Yoneda,et al.  Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A , 2000, Journal of Bone and Mineral Metabolism.

[84]  K. Kinzler,et al.  PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. , 1999, Cell.

[85]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[86]  E. Wang,et al.  Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. , 1993, Growth factors.

[87]  W Eisenmenger,et al.  Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. , 1987, Bone.